Please assess the completion status of the following clinical trial:

Trial Title: Trichomonas Vaginalis Recurrence Among HIV+ Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female~* 18 years or older~* HIV-positive~* TV positive by either wet preparation or culture~* ability to refrain from all alcohol use for 24 hours before and after taking oral metronidazole~* willing to take metronidazole treatment~Exclusion Criteria:~* pregnant~* incarcerated~* previously enrolled~* currently taking disulfiram~* alcoholism or known liver damage~* medical contraindications to metronidazole~* treated with metronidazole within the previous 14 days~* requires treatment for B.V. per Amsel's criteria

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single dose (Type: ACTIVE_COMPARATOR): Metronidazole 2 gm single dose
- 7 day dose (Type: ACTIVE_COMPARATOR): Metronidazole 500 mg dose x 7 days

Based on this trial design, predict the completion outcome and termination type (if applicable).